𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice

✍ Scribed by Colussi, C.; Berni, R.; Rosati, J.; Straino, S.; Vitale, S.; Spallotta, F.; Baruffi, S.; Bocchi, L.; Delucchi, F.; Rossi, S.

Book ID
111926914
Publisher
Oxford University Press
Year
2010
Tongue
English
Weight
416 KB
Volume
87
Category
Article
ISSN
0008-6363

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sequence-specific potentiation of topois
Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid
✍ Douglas C. Marchion; Elona Bicaku; Adil I. Daud; Victoria Richon; Daniel M. Sull πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 469 KB πŸ‘ 1 views

## Abstract Acetylation of histones leads to conformational changes of DNA. We have previously shown that the histone deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA), induced cell cycle arrest, differentiation, and apoptosis. In addition to their antitumor effects as single age